Little Green Pharma Ltd (ASX: LGP) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Little Green Pharma Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $57.96 million
P/E Ratio 4.62
Dividend Yield 0.00%
Shares Outstanding 827.98 million
Earnings per share -0.005
Dividend per share N/A
Year To Date Return -45.60%
Earnings Yield 21.67%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Little Green Pharma Ltd (ASX: LGP)
    Latest News

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Share Gainers

    Why is the Little Green Pharma (ASX:LGP) share price in the green today?

    A new agreement will see exclusivity of sales and distribution in Greece.

    Read more »

    Cannabis Shares

    Little Green Pharma (ASX:LGP) share price leaps 7% on revenue growth

    Patient demand for medicinal cannabis products has grown in Australia.

    Read more »

    A man in a wheelchair stretches both arms into the air in success.
    Healthcare Shares

    How did ASX healthcare shares perform in the FY22 first quarter?

    ASX healthcare shares have pivoted from the major benchmarks in Q1 to book gains.

    Read more »

    heavy lifting, lifting index, carrying weight, boy lifting dumbbell above his head
    Cannabis Shares

    Little Green Pharma (ASX:LGP) share price lifts as bosses reflect on a big year

    The Little Green Pharma share price is in the green today.

    Read more »

    a medical researcher places a cannabis plant bud into a test tube. She is wearing a white lab coat and protective equipment, including a mask, over her face and is in an outdoor setting.
    Cannabis Shares

    The Little Green Pharma (ASX:LGP) share price has fallen 7% this month

    September hasn't been Little Green Pharma's month. Here's what the company has been up to this month.

    Read more »

    Falling cannabis asx share price represented by cannabis leaves on a declining line graph
    ASX Share Market News

    What's going wrong for ASX cannabis shares lately?

    Why Aussie cannabis companies are worth watching right now...

    Read more »

    Hipster man puts head in hand as he talks on phone in front while sitting at a desk.
    ASX Share Market News

    Why the Little Green Pharma (ASX:LGP) share price has lost 20% since July

    The medicinal cannabis producer's shares have fallen heavily in recent times...

    Read more »

    A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares
    ASX Share Market News

    What's happening with the Little Green Pharma (ASX:LGP) share price today?

    The medicinal cannabis producer has failed to fly today after posting its latest quarterly results.

    Read more »

    little green pharma share price represented by cannabis leaf character jumping cheerfully
    Cannabis Shares

    Blazing it? How the top ASX cannabis shares performed in FY21

    How did ASX cannabis shares fare in FY21?

    Read more »

    A medical researcher works on a bichip, indicating share price movement in ASX tech companies
    Share Gainers

    These 3 ASX biotech shares are all up at least 120% in a year

    These 3 biotech shares have gone gangbusters across the past 12 months.

    Read more »

    Young adult male farmer standing smiling in his indoor greenhouse full of herbal cannabis plants at a cannabis cultivation facility
    Cannabis Shares

    Why the Little Green Pharma (ASX:LGP) share price fired up 8% today

    The Australian company is planting a big stake in Europe.

    Read more »

    women working with medicinal marijuana, indicating a share price movement in ASX cannabis shares
    Cannabis Shares

    Here's why the Little Green Pharma (ASX:LGP) share price is down 5%

    Following the TGA's clarification of distribution requirements, the Australian medicinal cannabis producer faces a change of rules.

    Read more »

    LGP ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Little Green Pharma Ltd

    Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. Its medicines are cultivated, without pesticides, in a hydroponic facility. The company was founded in 2017 and is headquartered in West Perth, Australia.

    LGP Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    09 Sep 2026 $0.07 $0.00 0.00% 340,320 $0.07 $0.07 $0.06
    08 Sep 2026 $0.07 $0.00 0.00% 320,585 $0.07 $0.07 $0.07
    07 Sep 2026 $0.07 $0.00 0.00% 380,156 $0.07 $0.07 $0.07
    04 Sep 2026 $0.07 $0.00 0.00% 474,754 $0.06 $0.07 $0.06
    03 Sep 2026 $0.06 $0.00 0.00% 146,785 $0.06 $0.07 $0.06
    02 Sep 2026 $0.06 $0.00 0.00% 13,775 $0.06 $0.06 $0.06
    01 Sep 2026 $0.06 $0.00 0.00% 455,953 $0.07 $0.07 $0.06
    31 Aug 2026 $0.07 $0.00 0.00% 298,622 $0.07 $0.07 $0.06
    28 Aug 2026 $0.07 $0.00 0.00% 514,787 $0.07 $0.07 $0.07
    27 Aug 2026 $0.07 $0.00 0.00% 135,260 $0.07 $0.07 $0.07
    26 Aug 2026 $0.07 $0.00 0.00% 453,873 $0.07 $0.07 $0.06
    25 Aug 2026 $0.07 $0.00 0.00% 81,780 $0.07 $0.07 $0.07
    24 Aug 2026 $0.07 $0.00 0.00% 173,886 $0.07 $0.07 $0.07
    21 Aug 2026 $0.07 $0.00 0.00% 80,777 $0.07 $0.07 $0.07
    20 Aug 2026 $0.07 $0.00 0.00% 128,200 $0.07 $0.07 $0.07
    19 Aug 2026 $0.07 $0.00 0.00% 56,033 $0.07 $0.07 $0.07
    18 Aug 2026 $0.07 $0.00 0.00% 189,409 $0.07 $0.08 $0.07
    17 Aug 2026 $0.07 $0.00 0.00% 187,666 $0.08 $0.08 $0.07
    14 Aug 2026 $0.07 $0.00 0.00% 609,208 $0.08 $0.08 $0.07
    13 Aug 2026 $0.08 $0.00 0.00% 115,704 $0.07 $0.08 $0.07
    12 Aug 2026 $0.07 $0.00 0.00% 37,965 $0.07 $0.07 $0.07
    11 Aug 2026 $0.08 $0.00 0.00% 177,960 $0.08 $0.08 $0.07

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    01 Jun 2026 Michael Lynch-Bell Buy 300,000 $25,500
    Conversion of securities.
    01 Jun 2026 Michael Lynch-Bell Exercise 300,000 $25,500
    Conversion of securities.
    01 Jun 2026 Paul Long Cancelled 3,000,000 $255,000
    Cancellation of securities. 1,000,000 rights
    28 May 2026 Fleta Solomon Sell 8,404 $790
    On-market trade.
    26 May 2026 Fleta Solomon Sell 5,000 $475
    On-market trade.
    26 Feb 2026 Michael Lynch-Bell Exercise 140,000 $15,400
    Conversion of securities. 300,000 rights
    26 Feb 2026 Michael Lynch-Bell Buy 140,000 $15,400
    Conversion of securities.
    26 Feb 2026 Neale Fong Exercise 70,000 $7,700
    Conversion of securities. 150,000 rights
    26 Feb 2026 Neale Fong Buy 70,000 $7,700
    Conversion of securities.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael David Lynch-Bell Non-Executive ChairmanNon-Executive Director Nov 2018
    Mr Lynch-Bell has experience as corporate finance executive and consultant. Mr Lynch-Bell Ernst & Young career was focused on auditing clients within the oil and gas sectors and later added mining to his portfolio. Mr Lynch-Bell has been involved advising companies on fundraising, reorganisations, transactions, corporate governance as well as IPOs. He is a member of the Risk committee.
    Mr Paul Long Chief Executive OfficerManaging Director Aug 2023
    Mr Long has expertise in the global medicinal cannabis sector and the capital markets. Mr Long worked as a consultant in enterprise health, health technology, and retail pharmaceutical sectors. Mr Long was a former Chief Executive Officer of Onsite Health Solutions.
    Mr Seth Yakatan Non-Executive Director Jun 2026
    --
    Mr Thomas Huppert Non-Executive Director Jun 2026
    --
    Mr Brent Dennison Non-Executive Chairman Jun 2026
    --
    Mr Alistair Warren Company Secretary Jul 2020
    -
    Ms Paula Butler Chief Financial Officer Jun 2026
    -
    Paula Butler Chief Financial Officer
    -
    Alistair Warren Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    UBS Nominees Pty Ltd 34,388,475 11.24%
    Thorney International Pty Ltd 22,690,049 7.42%
    Ms Fleta Jennifer Solomon 20,723,216 6.78%
    Barbright Australia Pty Ltd <Interquartz> Super <A/C> 13,732,793 4.49%
    BNP Paribas Nominees Pty Ltd Acf Clearstream 7,333,346 2.40%
    HSBC Custody Nominees (Australia) Limited 6,480,007 2.12%
    Mr Angus Caithness 5,751,441 1.88%
    Banquo Consulting Pty Ltd 5,413,333 1.77%
    Netwealth Investments Limited <Wrap> Services <A/C> 5,348,533 1.75%
    CG Nominees (Australia) Pty Ltd 4,147,061 1.36%
    Two Willows Pty Ltd <Two> Willows Superfund <A/C> 3,861,000 1.26%
    Citicorp Nominees Pty Limited 3,430,231 1.12%
    Jasforce Pty Ltd 2,883,878 0.94%
    Mr Suwandi Broto + Mrs Siew Broto 2,826,015 0.92%
    Finclear Services Pty Ltd <Superhero> Securities <A/C> 2,523,287 0.82%
    Mr Paul Frederick Long <The> Long <A/C> 2,426,191 0.79%
    Ms Jenny Lorraine Mckay <J> & K Mckay Family <A/C> 2,189,746 0.72%
    H & K Properties Pty Ltd 2,000,000 0.65%
    Mr Michael David Lynch-Bell 1,968,450 0.64%
    FSG (Holding) Pty Ltd 1,916,000 0.63%

    Profile

    since

    Note